bepridil and erythromycin

bepridil has been researched along with erythromycin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	3 (50.00)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ	1
Luurila, H; Neuvonen, PJ; Olkkola, KT	1

Trials

1 trial(s) available for bepridil and erythromycin

Article	Year
Interaction between erythromycin and the benzodiazepines diazepam and flunitrazepam. Pharmacology & toxicology, 1996, Volume: 78, Issue:2 Topics: Adult; Animals; Antioxidants; Aspartate Aminotransferases; Bepridil; Biphenyl Compounds; Cross-Over Studies; Diazepam; Double-Blind Method; Drug Interactions; Erythromycin; Female; Flunitrazepam; Free Radicals; Humans; L-Lactate Dehydrogenase; Lipid Peroxidation; Lipoxygenase Inhibitors; Liver; Male; Picrates; Rats; Rats, Wistar	1996

Article

Year

Interaction between erythromycin and the benzodiazepines diazepam and flunitrazepam.

Pharmacology & toxicology, 1996, Volume: 78, Issue:2

Topics: Adult; Animals; Antioxidants; Aspartate Aminotransferases; Bepridil; Biphenyl Compounds; Cross-Over Studies; Diazepam; Double-Blind Method; Drug Interactions; Erythromycin; Female; Flunitrazepam; Free Radicals; Humans; L-Lactate Dehydrogenase; Lipid Peroxidation; Lipoxygenase Inhibitors; Liver; Male; Picrates; Rats; Rats, Wistar

1996

Other Studies

5 other study(ies) available for bepridil and erythromycin

Article	Year
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents. Bioorganic & medicinal chemistry letters, 2004, Sep-20, Volume: 14, Issue:18 Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1 Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity	2013